Filtered By:
Specialty: Pharmaceuticals
This page shows you your search results in order of date. This is page number 8.
Order by Relevance | Date
Total 6905 results found since Jan 2013.
COVID-19 Vaccine Protection Lasts at Least Six Months After Second Dose
TUESDAY, Feb. 7, 2023 -- Vaccine protection against severe outcomes from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) lasts at least six months after the second dose, but protection is lower for older patients, according to a study...
Source: Drugs.com - Pharma News - February 7, 2023 Category: Pharmaceuticals Source Type: news
Women Who Live Healthy Lifestyles May Reduce Their Risk Of Long Covid By Half, Study Suggests
Between eight and 23 million Americans suffer from long Covid.
Source: Forbes.com Healthcare News - February 6, 2023 Category: Pharmaceuticals Authors: Ana Faguy, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Source Type: news
InnovationRx: A Mental Health Startup Unionizes; Plus, Covid Emergency To End In May
InnovationRx is your weekly digest of healthcare news. Sign up!
Source: Forbes.com Healthcare News - February 2, 2023 Category: Pharmaceuticals Authors: Katie Jennings, Forbes Staff Tags: Healthcare /healthcare Innovation /innovation Coronavirus Editors' Pick editors-pick Newsletter No Paywall no-paywall Source Type: news
What The End Of The Covid-19 Public Health Emergency Will Mean For Older Adults
Biden ’s decision buys a few more months under the emergency.
Source: Forbes.com Healthcare News - February 1, 2023 Category: Pharmaceuticals Authors: Howard Gleckman, Senior Contributor Tags: Personal Finance /personal-finance Money /money Innovation /innovation Healthcare /healthcare Decision Maker Content decisionmaker Coronavirus investing personalfinance Source Type: news
MSNBC Host Vossoughian Suffers Myocarditis After Common Cold, Yet Covid-19 Vaccine Claims Spread
NBC's Yasmin Vossoughian told viewers why she hasn't been on air for a few weeks and described what had happened.
Source: Forbes.com Healthcare News - February 1, 2023 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Business /business Media /media Coronavirus pharma Source Type: news
The Next Covid-19 Crisis, May 11th And Our Missing Healthcare Leadership
The Biden administration just announced on May 11 it will end our Pandemic emergency declaration and this could test both health care and the economy. Crippled by vacancies in key health care leadership, what will the “end” of the Covid-19 health emergency look like and who will even explain it?
Source: Forbes.com Healthcare News - February 1, 2023 Category: Pharmaceuticals Authors: Steve Brozak, Contributor Tags: Healthcare /healthcare Innovation /innovation Leadership /leadership Decision Maker Content decisionmaker Coronavirus business pharma Source Type: news
U.S. must address IP and market access barriers abroad to protect American innovation
PhRMA recentlysubmitted comments to the Office of the U.S. Trade Representative (USTR) ’s 2023 Special 301 Report. The comments highlight foreign government actions and policies that undermine American innovation, biopharmaceutical leadership and more than 4.4 millionAmerican jobs.
Source: The Catalyst - January 31, 2023 Category: Pharmaceuticals Authors: Ernest Kawka Tags: Intellectual Property Coronavirus TRIPS Waiver Source Type: news
Covid Public Health Emergencies Will End May 11, White House Says
The Biden administration will bring the years-long Covid-19 emergency declarations to an end on May 11, the White House announced Monday, as part of a pivot to treat the coronavirus as an endemic seasonal threat.
Source: Forbes.com Healthcare News - January 31, 2023 Category: Pharmaceuticals Tags: Business /business Healthcare /healthcare Source Type: news
Pfizer Expects Covid Vaccine And Pill Revenues Will Fall 60% In 2023
Shares of the pharmaceutical giant fell Tuesday as investors respond to lower projected sales for Pfizer ’s core products combatting Covid-19.
Source: Forbes.com Healthcare News - January 31, 2023 Category: Pharmaceuticals Authors: Derek Saul, Forbes Staff Tags: Business /business Money /money Markets /markets Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Education Source Type: news
Covid Public Health Emergencies Will End May 11, White House Says
The end of the Covid-19 emergency is likely to end wide access to free vaccines and tests.
Source: Forbes.com Healthcare News - January 31, 2023 Category: Pharmaceuticals Authors: Siladitya Ray, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Source Type: news
Rep. Katie Porter Says ‘Two Manufacturers Control 97%’ Of Covid-19 Vaccine Market
In a recent speech, Porter said, “We cannot continue to ask taxpayers to help cover the risk while letting Pharma collude to reap the profits.”
Source: Forbes.com Healthcare News - January 30, 2023 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science Coronavirus business pharma Source Type: news
Pandemic Nears ‘Transition’ Point—But It’s Still A Global Health Emergency, WHO Warns
A leading agency member said “we’re in a far better situation now” compared to a year ago.
Source: Forbes.com Healthcare News - January 30, 2023 Category: Pharmaceuticals Authors: Ty Roush, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Source Type: news
Bivalent Vaccine Provides Added Protection Against BA.5, XBB/XBB.1.5
THURSDAY, Jan. 26, 2023 -- Bivalent vaccines seem to provide additional protection against symptomatic BA.5 and XBB/XBB.1.5 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron sublineages, according to research published in the Jan....
Source: Drugs.com - Pharma News - January 26, 2023 Category: Pharmaceuticals Source Type: news
Pediatric SARS-CoV-2, MIS-C Differed in Delta, Omicron Waves
THURSDAY, Jan. 26, 2023 -- The clinical presentation of hospitalized children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive testing or multisystem inflammatory syndrome in children (MIS-C) differed in the delta and...
Source: Drugs.com - Pharma News - January 26, 2023 Category: Pharmaceuticals Source Type: news
A Covid Test Targeting The Fast-Spreading XBB.1.5 ‘Kraken’ Variant Is Being Developed By Scientists
The specialized test will help experts track the fast-spreading virus and develop new strategies to contain it, Roche said.
Source: Forbes.com Healthcare News - January 26, 2023 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Science /science Healthcare /healthcare Breaking breaking-news Coronavirus Source Type: news
